PDF
ZENODO
Published
2025-11-10
Section
Articles
How to Cite
How to Cite
IMMUNOMORPHOLOGICAL CHARACTERISTICS OF CERVICAL CANCER AND THEIR INTERRELATIONSHIPS
Abraykulov Ilhom Ramazonovich
Assistant of the Department of Oncology, Ophthalmology, Termez Branch of the Tashkent Medical Academy Otorhinolaryngology and Medical Radiology.
Keywords: cervical cancer, immunomorphology, tumor microenvironment, immune response, molecular markers, pathogenesis, prognosis.
Abstract
Cervical cancer remains one of the most prevalent malignancies among women worldwide, with complex immunomorphological features that influence its progression, diagnosis, and treatment outcomes. This article explores the immunomorphological characteristics of cervical cancer, focusing on the structural and functional changes in tumor cells and the surrounding microenvironment. Special attention is given to the role of immune cells, cytokines, and molecular markers that reflect the immune response and tumor aggressiveness. The interrelationships between these parameters are analyzed to better understand the mechanisms of tumor development, invasion, and metastasis. The findings highlight the significance of immunomorphological assessment in improving diagnostic accuracy, prognostic evaluation, and the selection of effective therapeutic strategies for patients with cervical cancer
References
1. Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015). Human papillomavirus molecular biology and disease association. Reviews in Medical Virology, 25(S1), 2–23.
2. zur Hausen, H. (2009). Papillomaviruses in the causation of human cancers – a brief historical account. Virology, 384(2), 260–265.
3. Tjalma, W. A., Fiander, A., Reich, O., et al. (2013). Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. International Journal of Cancer, 132(4), 854–867.
4. Wu, Y., Guo, H., Zeng, Q., et al. (2020). Immune microenvironment and immunotherapy of cervical cancer. Frontiers in Immunology, 11, 575765.
5. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69–90.
6. Lechner, M., & Thierauf, J. (2019). Role of the immune system in HPV-associated head and neck and cervical cancers. Frontiers in Oncology, 9, 1074.
7. Piersma, S. J. (2011). Immunosuppressive tumor microenvironment in cervical cancer patients. Cancer Microenvironment, 4(3), 361–375.
8. Li, H., & Liu, F. (2021). PD-L1 expression and tumor-infiltrating lymphocytes in cervical carcinoma: Correlation with clinical outcomes. BMC Cancer, 21(1), 1–9.
